Lili Zeng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lili Zeng has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Walter Reisner
Department of Physics
9 shared publications Guo-Yuan Yang
Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China
6 shared publicationsYu Zhang
Department of Neurology and Institute of Neurology, Ruijin Hospital North, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
5 shared publications- Ji-Rong He
Department of Neurology, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China
4 shared publications Kai-Qi Ding
Affiliation Department of Neurology and Institute of Neurology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
4 shared publicationsXuan-Qiang Tu
Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
4 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19, 1972044
Inhibition of miR-140-5p attenuates OGD/R-induced neuronal injury by targeting IL1RAPL1
Objective: Cerebral ischemia–reperfusion (I/R) injury is a major contributor to neuronal damage and long-term neurological dysfunction after stroke. Our previous studies demonstrated that miR-140-5p expression is markedly upregulated following cerebral ischemia and that in vivo overexpression of miR-140-5p exacerbates cognitive impairment, suppresses neurogenesis, and promotes neuronal death in ischemic mouse models; however, its molecular mechanisms remain unclear. This study aimed to investigate the downstream molecular targets of miR-140-5p and to elucidate the mechanisms by which miR-140-5p regulates neuronal injury after I/R. Methods: We established an oxygen–glucose deprivation/reoxygenation (OGD/R) model in primary cortical neurons and assessed viability via Cell Counting Kit-8 (CCK-8). miR-140-5p expression after OGD/R was examined, and loss-of-function experiments evaluated the effects of miR-140-5p inhibition. Synaptic integrity was assessed by immunofluorescence, and inflammatory cytokines by enzyme-linked immunosorbent assay (ELISA). Proteomic analysis identified potential downstream targets, which were validated via Western blotting and dual-luciferase reporter assays. Results: We found that miR-140-5p expression was significantly upregulated in mouse cortical neurons after OGD/R. Functional inhibition of miR-140-5p markedly enhanced neuronal survival, promoted synaptic remodeling, and attenuated inflammatory responses following OGD/R injury. Mechanistically, miR-140-5p was shown to directly target Il1rapl1 and modulate downstream c-Jun N-terminal kinase (JNK) signaling, thereby regulating neuronal viability, inflammation, and synaptic plasticity under ischemia–reperfusion conditions. Conclusion: This study reveals a novel miR-140-5p–mediated regulatory mechanism in neuronal injury following cerebral ischemia–reperfusion and suggests a potential therapeutic target for ischemic brain injury.
- 23 October 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19, 1972044
Open AccessInhibition of miR-140-5p attenuates OGD/R-induced neuronal injury by targeting IL1RAPL1
Objective: Cerebral ischemia–reperfusion (I/R) injury is a major contributor to neuronal damage and long-term neurological dysfunction after stroke. Our previous studies demonstrated that miR-140-5p expression is markedly upregulated following cerebral ischemia and that in vivo overexpression of miR-140-5p exacerbates cognitive impairment, suppresses neurogenesis, and promotes neuronal death in ischemic mouse models; however, its molecular mechanisms remain unclear. This study aimed to investigate the downstream molecular targets of miR-140-5p and to elucidate the mechanisms by which miR-140-5p regulates neuronal injury after I/R. Methods: We established an oxygen–glucose deprivation/reoxygenation (OGD/R) model in primary cortical neurons and assessed viability via Cell Counting Kit-8 (CCK-8). miR-140-5p expression after OGD/R was examined, and loss-of-function experiments evaluated the effects of miR-140-5p inhibition. Synaptic integrity was assessed by immunofluorescence, and inflammatory cytokines by enzyme-linked immunosorbent assay (ELISA). Proteomic analysis identified potential downstream targets, which were validated via Western blotting and dual-luciferase reporter assays. Results: We found that miR-140-5p expression was significantly upregulated in mouse cortical neurons after OGD/R. Functional inhibition of miR-140-5p markedly enhanced neuronal survival, promoted synaptic remodeling, and attenuated inflammatory responses following OGD/R injury. Mechanistically, miR-140-5p was shown to directly target Il1rapl1 and modulate downstream c-Jun N-terminal kinase (JNK) signaling, thereby regulating neuronal viability, inflammation, and synaptic plasticity under ischemia–reperfusion conditions. Conclusion: This study reveals a novel miR-140-5p–mediated regulatory mechanism in neuronal injury following cerebral ischemia–reperfusion and suggests a potential therapeutic target for ischemic brain injury.
- Open Access
- 29 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (35) , e44128
Cerebral small vessel disease related to a heterozygous missense mutation in HTRA1: A case report
Rationale: Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy is a rare genetic condition classified as a cerebral small vessel disease (CSVD). Traditionally, this disorder has been linked to either homozygous or compound heterozygous mutations in the high-temperature requirement A serine peptidase 1 (HTRA1) gene. Nevertheless, contemporary research has uncovered that heterozygous mutations in HTRA1 can also manifest in patients displaying patterns of autosomal dominant inheritance. In order to explore the association between the types of HTRA1 gene mutations and the genetic pattern of CSVD, in this case report, we identified a case of autosomal dominant hereditary CSVD due to a new heterozygous mutation of the HTRA1 gene in an Asian female. Patient concerns: The patient experienced a later onset of cognitive disorder and gait disturbances, and notably, there was an absence of alopecia and spondylosis, which are commonly observed extra-neurological features associated with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Neuroimaging conducted through magnetic resonance imaging revealed extensive white matter lesions and microbleeds localized within the brainstem and both cerebral hemispheres. Utilizing next-generation sequencing techniques, a novel heterozygous missense mutation in the HTRA1 gene (c.524 T>A:p.V175E) was identified. Diagnoses: The patient was diagnosed as HTRA1-related autosomal dominant CSVD. Interventions: The patient was treated with donepezil and quetiapine because of the memory impairments and visual hallucination in the early stage of the disease course. After the diagnosis of CSVD and the clinical manifestations of depressive tendencies, we treated her with Cilostazol and Sertraline additionally. Outcomes: The patient symptoms were relieved temporarily. As the disease progresses, the patient experienced 2 episodes of epilepsy and 1 cerebral infarction event. Lessons: This case suggests that individuals with the heterozygous HTRA1 mutation at V175E may also present clinical characteristics consistent with hereditary CSVD, expanding the recognized spectrum of HTRA1 mutations related to autosomal dominant small vessel disease.
- 29 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (35) , e44128
Open AccessCerebral small vessel disease related to a heterozygous missense mutation in HTRA1: A case report
Rationale: Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy is a rare genetic condition classified as a cerebral small vessel disease (CSVD). Traditionally, this disorder has been linked to either homozygous or compound heterozygous mutations in the high-temperature requirement A serine peptidase 1 (HTRA1) gene. Nevertheless, contemporary research has uncovered that heterozygous mutations in HTRA1 can also manifest in patients displaying patterns of autosomal dominant inheritance. In order to explore the association between the types of HTRA1 gene mutations and the genetic pattern of CSVD, in this case report, we identified a case of autosomal dominant hereditary CSVD due to a new heterozygous mutation of the HTRA1 gene in an Asian female. Patient concerns: The patient experienced a later onset of cognitive disorder and gait disturbances, and notably, there was an absence of alopecia and spondylosis, which are commonly observed extra-neurological features associated with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Neuroimaging conducted through magnetic resonance imaging revealed extensive white matter lesions and microbleeds localized within the brainstem and both cerebral hemispheres. Utilizing next-generation sequencing techniques, a novel heterozygous missense mutation in the HTRA1 gene (c.524 T>A:p.V175E) was identified. Diagnoses: The patient was diagnosed as HTRA1-related autosomal dominant CSVD. Interventions: The patient was treated with donepezil and quetiapine because of the memory impairments and visual hallucination in the early stage of the disease course. After the diagnosis of CSVD and the clinical manifestations of depressive tendencies, we treated her with Cilostazol and Sertraline additionally. Outcomes: The patient symptoms were relieved temporarily. As the disease progresses, the patient experienced 2 episodes of epilepsy and 1 cerebral infarction event. Lessons: This case suggests that individuals with the heterozygous HTRA1 mutation at V175E may also present clinical characteristics consistent with hereditary CSVD, expanding the recognized spectrum of HTRA1 mutations related to autosomal dominant small vessel disease.
- Open Access
- 31 October 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (10) , e0312534
Peripapillary vessels density is closely related to cerebral white matter hyperintensities: An OCTA study
Background: Chronic cerebral hypoperfusion triggers the development of white matter hyperintensities (WMHs), common in cerebral small vessel disease (CSVD). However, conventional imaging techniques cannot visualize cerebral small vessels. The retina, a direct extension of the central nervous system, has an unclear correlation with WMHs. This study employs Optical coherence tomographic angiography (OCTA) to investigate vascular changes in the retina and explore its correlation with WMHs, aiming to provide a new method for assessing perfusion in early ischemic brain WMHs. Methods: Forty-nine patients with WMHs were stratified into mild and moderate/severe WMHs groups based on MRI findings, utilizing the Fazekas and Scheltens scales. OCTA assessed fundus vessel microcirculation. Logistic regression analyzed the correlation between ocular fundus microcirculation and WMH severity and location. Additionally, ROC curves evaluated the diagnostic efficacy of each fundus vascular microcirculation index in determining WMH severity. Results: After adjusting for multiple confounders, finding consistently indicated that the moderate/ severe WMHs group exhibited lower vessel density (VD) in the superior quadrant of the inner peripapillary region compared to the mild group [OR = 0.487, CI (0.255,0.929), p < 0.05]. ROC curves revealed that when combined with age, diabetes, and superior quadrant VD of the inner peripapillary region, specificity could be increased to 94.1%. Conclusion: Peripapillary vessel density correlates closely with the severity of cerebral WMHs. Early morphological changes due to chronic hypoperfusion may initiate from the inner layer of the optic disc, and OCTA could offer a novel method for evaluating blood perfusion in ischemic WMHs.
- 31 October 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (10) , e0312534
Open AccessPeripapillary vessels density is closely related to cerebral white matter hyperintensities: An OCTA study
Background: Chronic cerebral hypoperfusion triggers the development of white matter hyperintensities (WMHs), common in cerebral small vessel disease (CSVD). However, conventional imaging techniques cannot visualize cerebral small vessels. The retina, a direct extension of the central nervous system, has an unclear correlation with WMHs. This study employs Optical coherence tomographic angiography (OCTA) to investigate vascular changes in the retina and explore its correlation with WMHs, aiming to provide a new method for assessing perfusion in early ischemic brain WMHs. Methods: Forty-nine patients with WMHs were stratified into mild and moderate/severe WMHs groups based on MRI findings, utilizing the Fazekas and Scheltens scales. OCTA assessed fundus vessel microcirculation. Logistic regression analyzed the correlation between ocular fundus microcirculation and WMH severity and location. Additionally, ROC curves evaluated the diagnostic efficacy of each fundus vascular microcirculation index in determining WMH severity. Results: After adjusting for multiple confounders, finding consistently indicated that the moderate/ severe WMHs group exhibited lower vessel density (VD) in the superior quadrant of the inner peripapillary region compared to the mild group [OR = 0.487, CI (0.255,0.929), p < 0.05]. ROC curves revealed that when combined with age, diabetes, and superior quadrant VD of the inner peripapillary region, specificity could be increased to 94.1%. Conclusion: Peripapillary vessel density correlates closely with the severity of cerebral WMHs. Early morphological changes due to chronic hypoperfusion may initiate from the inner layer of the optic disc, and OCTA could offer a novel method for evaluating blood perfusion in ischemic WMHs.
- Open Access
- 3 June 2024
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 16, 1404756
Development and validation of a predictive model for severe white matter hyperintensity with obesity
Purpose: The purpose of the present study was to identify predictors of severe white matter hyperintensity (WMH) with obesity (SWO), and to build a prediction model for screening obese people with severe WMH without Nuclear Magnetic Resonance Imaging (MRI) examination.Patients subjects and methods: From September 2020 to October 2021, 650 patients with WMH were recruited consecutively. The subjects were divided into two groups, SWO group and non-SWO group. Univariate and Logistic regression analysis were was applied to explore the potential predictors of SWO. The Youden index method was adopted to determine the best cut-off value in the establishment of the prediction model of SWO. Each parameter had two options, low and high. The score table of the prediction model and nomogram based on the logistic regression were constructed. Of the 650 subjects, 487 subjects (75%) were randomly assigned to the training group and 163 subjects (25%) to the validation group. By resampling the area under the curve (AUC) of the subject’s operating characteristics and calibration curves 1,000 times, nomogram performance was verified. A decision curve analysis (DCA) was used to evaluate the nomogram’s clinical usefulness. By resampling the area under the curve (AUC) of the subject’s operating characteristics and calibration curves 1,000 times, nomogram performance was verified. A decision curve analysis (DCA) was used to evaluate the nomogram’s clinical usefulness.Results: Logistic regression demonstrated that hypertension, uric acid (UA), complement 3 (C3) and Interleukin 8 (IL-8) were independent risk factors for SWO. Hypertension, UA, C3, IL-8, folic acid (FA), fasting C-peptide (FCP) and eosinophil could be used to predict the occurrence of SWO in the prediction models, with a good diagnostic performance, Areas Under Curves (AUC) of Total score was 0.823 (95% CI: 0.760–0.885, p < 0.001), sensitivity of 60.0%, specificity of 91.4%. In the development group, the nomogram’s AUC (C statistic) was 0.829 (95% CI: 0.760–0.899), while in the validation group, it was 0.835 (95% CI: 0.696, 0.975). In both the development and validation groups, the calibration curves following 1,000 bootstraps showed a satisfactory fit between the observed and predicted probabilities. DCA showed that the nomogram had great clinical utility.Conclusion: Hypertension, UA, C3, IL-8, FA, FCP and eosinophil models had the potential to predict the incidence of SWO. When the total score of the model exceeded 9 points, the risk of SWO would increase significantly, and the nomogram enabled visualization of the patient’s WMH risk. The application prospect of our models mainly lied in the convenient screening of SWO without MRI examination in order to detect SWO and control the WMH hazards early.
- 3 June 2024
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 16, 1404756
Open AccessDevelopment and validation of a predictive model for severe white matter hyperintensity with obesity
Purpose: The purpose of the present study was to identify predictors of severe white matter hyperintensity (WMH) with obesity (SWO), and to build a prediction model for screening obese people with severe WMH without Nuclear Magnetic Resonance Imaging (MRI) examination.Patients subjects and methods: From September 2020 to October 2021, 650 patients with WMH were recruited consecutively. The subjects were divided into two groups, SWO group and non-SWO group. Univariate and Logistic regression analysis were was applied to explore the potential predictors of SWO. The Youden index method was adopted to determine the best cut-off value in the establishment of the prediction model of SWO. Each parameter had two options, low and high. The score table of the prediction model and nomogram based on the logistic regression were constructed. Of the 650 subjects, 487 subjects (75%) were randomly assigned to the training group and 163 subjects (25%) to the validation group. By resampling the area under the curve (AUC) of the subject’s operating characteristics and calibration curves 1,000 times, nomogram performance was verified. A decision curve analysis (DCA) was used to evaluate the nomogram’s clinical usefulness. By resampling the area under the curve (AUC) of the subject’s operating characteristics and calibration curves 1,000 times, nomogram performance was verified. A decision curve analysis (DCA) was used to evaluate the nomogram’s clinical usefulness.Results: Logistic regression demonstrated that hypertension, uric acid (UA), complement 3 (C3) and Interleukin 8 (IL-8) were independent risk factors for SWO. Hypertension, UA, C3, IL-8, folic acid (FA), fasting C-peptide (FCP) and eosinophil could be used to predict the occurrence of SWO in the prediction models, with a good diagnostic performance, Areas Under Curves (AUC) of Total score was 0.823 (95% CI: 0.760–0.885, p < 0.001), sensitivity of 60.0%, specificity of 91.4%. In the development group, the nomogram’s AUC (C statistic) was 0.829 (95% CI: 0.760–0.899), while in the validation group, it was 0.835 (95% CI: 0.696, 0.975). In both the development and validation groups, the calibration curves following 1,000 bootstraps showed a satisfactory fit between the observed and predicted probabilities. DCA showed that the nomogram had great clinical utility.Conclusion: Hypertension, UA, C3, IL-8, FA, FCP and eosinophil models had the potential to predict the incidence of SWO. When the total score of the model exceeded 9 points, the risk of SWO would increase significantly, and the nomogram enabled visualization of the patient’s WMH risk. The application prospect of our models mainly lied in the convenient screening of SWO without MRI examination in order to detect SWO and control the WMH hazards early.
- 20 February 2024
- Published by American Physical Society (APS) in Physical Review E
- Vol. 109 (2) , 024501
Transient physics in the compression and mixing dynamics of two nanochannel-confined polymer chains
We use molecular dynamics (MD) simulation and nanofluidic experiments to probe the non-equilibrium transient physics of two nanochannel-confined polymers driven against a permeable barrier in a flow field. For chains with a persistence length smaller than the channel diameter , both simulation and experiment with dsDNA reveal nonuniform mixing of the two chains, with one chain dominating locally in what we term “aggregates.” Aggregates undergo stochastic dynamics, persisting for a limited time, then disappearing and reforming. Whereas aggregate-prone mixing occurs immediately at sufficiently high flow speeds, chains stay segregated at intermediate flow for some time, often attempting to mix multiple times, before suddenly successfully mixing. Observation of successful mixing nucleation events in nanofluidic experiments reveal that they arise through a peculiar “back-propagation” mechanism whereby the upstream chain, closest to the barrier, penetrates and passes through the downstream chain (farthest from the barrier) moving against the flow direction. Simulations suggest that the observed back-propagation nucleation mechanism is favored at intermediate flow speeds and arises from a special configuration where the upstream chain exhibits one or more folds facing the downstream chain, while the downstream chain has an unfolded chain end facing upstream.- 20 February 2024
- Published by American Physical Society (APS) in Physical Review E
- Vol. 109 (2) , 024501
Transient physics in the compression and mixing dynamics of two nanochannel-confined polymer chains
We use molecular dynamics (MD) simulation and nanofluidic experiments to probe the non-equilibrium transient physics of two nanochannel-confined polymers driven against a permeable barrier in a flow field. For chains with a persistence length smaller than the channel diameter , both simulation and experiment with dsDNA reveal nonuniform mixing of the two chains, with one chain dominating locally in what we term “aggregates.” Aggregates undergo stochastic dynamics, persisting for a limited time, then disappearing and reforming. Whereas aggregate-prone mixing occurs immediately at sufficiently high flow speeds, chains stay segregated at intermediate flow for some time, often attempting to mix multiple times, before suddenly successfully mixing. Observation of successful mixing nucleation events in nanofluidic experiments reveal that they arise through a peculiar “back-propagation” mechanism whereby the upstream chain, closest to the barrier, penetrates and passes through the downstream chain (farthest from the barrier) moving against the flow direction. Simulations suggest that the observed back-propagation nucleation mechanism is favored at intermediate flow speeds and arises from a special configuration where the upstream chain exhibits one or more folds facing the downstream chain, while the downstream chain has an unfolded chain end facing upstream.- 27 September 2023
- Published by Springer Nature in The European Physical Journal E
- Vol. 46 (9) , 1-13
Mixing and demixing arising from compression of two semiflexible polymer chains in nanochannels
We use molecular dynamics simulation to probe the non-equilibrium physics of two nanochannel-confined semiflexible polymers in a homogeneous flow field. We
- 27 September 2023
- Published by Springer Nature in The European Physical Journal E
- Vol. 46 (9) , 1-13
Mixing and demixing arising from compression of two semiflexible polymer chains in nanochannels
We use molecular dynamics simulation to probe the non-equilibrium physics of two nanochannel-confined semiflexible polymers in a homogeneous flow field. We
- Open Access
- 8 September 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (36) , e34682
Idiopathic hypereosinophilic syndrome presenting as capsular warning syndrome: A case report and literature review
Rationale: Few reports of idiopathic hypereosinophilic syndrome exist presenting as ischemic cerebrovascular disease, and the majority are watershed infarction. We report the first case of idiopathic hypereosinophilic syndrome that has clinical features of capsular warning syndrome lasting 6 weeks. Patient concerns: A 26-year-old man complained of recurrent right limb weakness, accompanying slurred speech, and right facial paresthesia. Diagnoses: The patient was diagnosed with idiopathic hypereosinophilic syndrome (IHES). Interventions: Adequate glucocorticoid and anticoagulant treatments were given. Outcomes: The patient’s motor ability improved, and he was discharged 2 weeks later. Muscle strength in the right-side extremities had fully recovered at a 3-month follow-up after discharge. Lessons: This case suggests that idiopathic hypereosinophilic syndrome should be considered as a cause of capsular warning syndrome, and the dose of glucocorticoid and the efficacy evaluation index needs to be reevaluated for the treatment of ischemic cerebrovascular disease associated with idiopathic hypereosinophilic syndrome.
- 8 September 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (36) , e34682
Open AccessIdiopathic hypereosinophilic syndrome presenting as capsular warning syndrome: A case report and literature review
Rationale: Few reports of idiopathic hypereosinophilic syndrome exist presenting as ischemic cerebrovascular disease, and the majority are watershed infarction. We report the first case of idiopathic hypereosinophilic syndrome that has clinical features of capsular warning syndrome lasting 6 weeks. Patient concerns: A 26-year-old man complained of recurrent right limb weakness, accompanying slurred speech, and right facial paresthesia. Diagnoses: The patient was diagnosed with idiopathic hypereosinophilic syndrome (IHES). Interventions: Adequate glucocorticoid and anticoagulant treatments were given. Outcomes: The patient’s motor ability improved, and he was discharged 2 weeks later. Muscle strength in the right-side extremities had fully recovered at a 3-month follow-up after discharge. Lessons: This case suggests that idiopathic hypereosinophilic syndrome should be considered as a cause of capsular warning syndrome, and the dose of glucocorticoid and the efficacy evaluation index needs to be reevaluated for the treatment of ischemic cerebrovascular disease associated with idiopathic hypereosinophilic syndrome.
- Open Access
- 23 August 2023
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1160110
Case report: Hereditary spastic paraplegia with a novel homozygous mutation in ZFYVE26
Hereditary spastic paraplegia (HSP) is a group of neurodegenerative diseases with genetic and clinical heterogeneity characterized by spasticity and weakness of the lower limbs. It includes four genetic inheritance forms: autosomal dominant inheritance (AD), autosomal recessive inheritance (AR), X-linked inheritance, and mitochondrial inheritance. To date, more than 82 gene loci have been found to cause HSP, and SPG15 (ZFYVE26) is one of the most common autosomal recessive hereditary spastic paraplegias (ARHSPs) with a thin corpus callosum (TCC), presents with early cognitive impairment and slowly progressive leg weakness. Here, we reported a homozygous pathogenic variant in ZFYVE26. A 19-year-old Chinese girl was admitted to our hospital presenting with a 2-year progressive bilateral leg spasticity and weakness; early cognitive impairment; corpus callosum dysplasia; chronic neurogenic injury of the medulla oblongata supplied muscles; and bilateral upper and lower limbs on electromyogram (EMG). Based on these clinical and electrophysiological features, HSP was suspected. Exome sequencing of the family was performed by high-throughput sequencing, and an analysis of the patient showed a ZFYVE26 NM_015346: c.7111dupA p.(M2371Nfs*51) homozygous mutation. This case reported a new ZFYVE26 pathogenic variant, which was different from the SPG15 gene mutation reported earlier.
- 23 August 2023
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1160110
Open AccessCase report: Hereditary spastic paraplegia with a novel homozygous mutation in ZFYVE26
Hereditary spastic paraplegia (HSP) is a group of neurodegenerative diseases with genetic and clinical heterogeneity characterized by spasticity and weakness of the lower limbs. It includes four genetic inheritance forms: autosomal dominant inheritance (AD), autosomal recessive inheritance (AR), X-linked inheritance, and mitochondrial inheritance. To date, more than 82 gene loci have been found to cause HSP, and SPG15 (ZFYVE26) is one of the most common autosomal recessive hereditary spastic paraplegias (ARHSPs) with a thin corpus callosum (TCC), presents with early cognitive impairment and slowly progressive leg weakness. Here, we reported a homozygous pathogenic variant in ZFYVE26. A 19-year-old Chinese girl was admitted to our hospital presenting with a 2-year progressive bilateral leg spasticity and weakness; early cognitive impairment; corpus callosum dysplasia; chronic neurogenic injury of the medulla oblongata supplied muscles; and bilateral upper and lower limbs on electromyogram (EMG). Based on these clinical and electrophysiological features, HSP was suspected. Exome sequencing of the family was performed by high-throughput sequencing, and an analysis of the patient showed a ZFYVE26 NM_015346: c.7111dupA p.(M2371Nfs*51) homozygous mutation. This case reported a new ZFYVE26 pathogenic variant, which was different from the SPG15 gene mutation reported earlier.
- 7 August 2023
- Published by Royal Society of Chemistry (RSC) in Soft Matter
- Vol. 19 (34) , 6545-6555
Characterizing interaction of multiple nanocavity confined plasmids in presence of large DNA model nucleoid
Bacteria have numerous large dsDNA molecules that freely interact within the cell, including multiple plasmids, primary and secondary chromosomes. The cell membrane maintains a micron-scale confinement, ensuring that the dsDNA species are proximal at all times and interact strongly in a manner influenced by the cell morphology (e.g. whether cell geometry is spherical or anisotropic). These interactions lead to non-uniform spatial organization and complex dynamics, including segregation of plasmid DNA to polar and membrane proximal regions. However, exactly how this organization arises, how it depends on cell morphology and number of interacting dsDNA species are under debate. Here, using an in vitro nanofluidic model, featuring a cavity that can be opened and closed in situ, we address how plasmid copy number and confinement geometry alter plasmid spatial distribution and dynamics. We find that increasing the plasmid number alters the plasmid spatial distribution and shortens the plasmid polar dwell time; sharper cavity end curvature leads to longer plasmid dwell times.
- 7 August 2023
- Published by Royal Society of Chemistry (RSC) in Soft Matter
- Vol. 19 (34) , 6545-6555
Characterizing interaction of multiple nanocavity confined plasmids in presence of large DNA model nucleoid
Bacteria have numerous large dsDNA molecules that freely interact within the cell, including multiple plasmids, primary and secondary chromosomes. The cell membrane maintains a micron-scale confinement, ensuring that the dsDNA species are proximal at all times and interact strongly in a manner influenced by the cell morphology (e.g. whether cell geometry is spherical or anisotropic). These interactions lead to non-uniform spatial organization and complex dynamics, including segregation of plasmid DNA to polar and membrane proximal regions. However, exactly how this organization arises, how it depends on cell morphology and number of interacting dsDNA species are under debate. Here, using an in vitro nanofluidic model, featuring a cavity that can be opened and closed in situ, we address how plasmid copy number and confinement geometry alter plasmid spatial distribution and dynamics. We find that increasing the plasmid number alters the plasmid spatial distribution and shortens the plasmid polar dwell time; sharper cavity end curvature leads to longer plasmid dwell times.
- Open Access
- 20 November 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (11) , 1587
Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy
Patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) seropositive for autoantibodies against nodal and paranodal proteins display distinct clinical presentations. In the latest study, CIDP with autoantibodies against paranodal proteins was defined as autoimmune nodopathy (AN). We herein present a case of 39-year-old male with anti- neurofascin (NF) 155 and NF186 IgG4 antibody with gait disturbance and tremor, who was followed up for 4 months and demonstrated clinical improvements after apparently effective rituximab therapy. In addition, a literature review was conducted to investigate the clinical characteristics of anti-NF155/NF186-positive AN.
- 20 November 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (11) , 1587
Open AccessAnti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy
Patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) seropositive for autoantibodies against nodal and paranodal proteins display distinct clinical presentations. In the latest study, CIDP with autoantibodies against paranodal proteins was defined as autoimmune nodopathy (AN). We herein present a case of 39-year-old male with anti- neurofascin (NF) 155 and NF186 IgG4 antibody with gait disturbance and tremor, who was followed up for 4 months and demonstrated clinical improvements after apparently effective rituximab therapy. In addition, a literature review was conducted to investigate the clinical characteristics of anti-NF155/NF186-positive AN.